Brief

"On July 8, 2025, Inex Corporation unveiled a groundbreaking technology that allows for real-time prediction of three types of colon lesion pathology. The AI-based software, ENAD CADx, received official approval from the Ministry of Food and Drug Safety and has been praised for its innovative feature of classifying lesions into three categories: adenoma/neoplasm, hyperplastic polyp, and serrated sessile lesion."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Health Industry Development Institute (KHIDI)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies